Live feed08:59:48·287dANALYSTRatingvia QuantisnowH.C. Wainwright resumed coverage on Arcturus Therapeutics with a new price targetByQuantisnow·Wall Street's wire, on your screen.ARCT· Arcturus Therapeutics Holdings Inc.Health CareOriginal source